FDA Investigator Susan D Yuscius

Susan D Yuscius has conducted inspections on 320 sites in 35 countries as of 13 Jul 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
320
Last Inspection Date:
13 Jul 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Brazil, New Zealand, Japan, India, Argentina, United Kingdom of Great Britain and Northern Ireland, Serbia, France, Canada, Czechia, Slovakia, Malta, Netherlands, Romania, Ireland, Poland, Switzerland, Denmark, Germany, Sweden, Colombia, Korea (Republic of), Latvia, Austria, Croatia, Hong Kong, Mexico, South Africa, Belgium, Israel, Dominican Republic, Lithuania, Spain, Italy
FDA Investigators that have inspected at least one site in common with Susan D Yuscius:
Adam J Taylor, Alan M Barker, Alanna L Mussawwir Bias, Alicia M Mozzachio, Allen F Hall, Althea A Williams, Amy M Cramer, Amy Wyan Mai, Ana E Morales, Anastasia M Shields, Anders W Evenson, Andrace L Deyampert, Andrew A Hoopes, Andrew A Leboeuf, Angela Shepas, Annette Melendez, Anthony E Keller, RPh, Ashley L Reiber, Atul J Agrawal, Audrey Dela Cruz, Azza Talaat, Barbara A Rusin, Barbara M Frazier, Bei Y He, Bradley J Maunder, Brandy D Brown, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brian P Putz, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carmen Y Fisher, Carrie Ann Plucinski, Charles M Edwards, Charlie P Booker, Cheryl A Grandinetti, Christina A Miller, Christopher D Leach, Colleen E Burke, Conner N Mann, Constantin Y Philopoulos, Courtney N Long, Courtney R Bratina, Craig A Garmendia, Cynthia A Harris, MD, RN, Cynthia A Palmer, Cynthia Jim, CSO, Cynthia L Rakestraw, Daniel L Aisen, Dariusz Galezowski, David J Gasparovich, David Perkins, Debra I Love, Debra Lboyd Seale, Denise M Digiulio, Dipesh K Shah, Dolores Harper, Don H Bark, PhD, Donna K Speer, Doretha M Tonkins, Dr. Barbara D Paul, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Eboni S Funderburk, Edwardstine J Reese, Elizabeth L Holmes, Elizabeth L Philpy, Ellen P Madigan, Eric M Mueller, PharmD, Eric S Pittman, Erin M Mcdowell, Esther A Ofori, Farhana Khan, Felix J Marrero, Felix Maldonado, Francis A Guidry, Fulton A Varner, Gajendiran Mahadevan, PhD, Gene R Gunn, Geoffrey K Kilili, George C Amedro, Gregson A Joseph, Hasan A Irier, PhD, Hassan Ali, Hugh M Mcclure, II, Jacob G Lutz, James L Finn, James M Kewley, James P Duggan, James W Plucinski, Janae D Price, Javier O Vega, Jeanne J Chiu, Jeanne J Thai, Jennifer C Adams, Jennifer C Johnson, Jennifer L Sheehan, Jesse A Vazquez, Jessica L Pressley, Jill J Tillman, John A Iwen, John A Kadavil, PhD, John M Seale, José E Meléndez, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joseph J Vannelli, Joseph L Despins, PhD, Joseph R Lambert, Joseph R Strelnik, Joshua M Adams, Joy P Matthias, Justin R Hays, Kara A Scheibner, PhD, Karen C Daugherty, Karen Emasley Joseph, Karen L Kosar, Karen M Cooper, Karen M Kondas, Kassa Ayalew, MD, Kathleen B Swat, Kathleen S Tormey, Kent A Conforti, Kham Phommachanh, Kinh Q Mac, Kip J Hanks, Kshitij A Patkar, Kujtim Sadiku, Lakecha N Lewis, Larry F Hallberg, Larry K Austin, Lata C Mathew, PhD, Laura E Garcia, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurie B Frazier, Lawrence Y Lee, PhD, LCDR Matthew R Mcnew, MPH, REHS/RS, Lee Terry Moore, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Liliya V Bubiy, Linda E Whitehead, Linda S Leja, Lisa Hayka, Lisa Hornback, Lisa L Flores, Lisa P Oakes, Logan T Williams, Lynda L Lanning, Marc A Jackson, Jr, Marcellinus D Dordunoo, Marcia A Worley, Margaret Torres Vazquez, Maria A Reed, Mark G Peterson, Mark I Kaspar, Martin K Yau, PhD, Mathew T Thomas, MD, Melkamu Getie Kebtie, PhD, Michael P Sheehan, Michael R Giammanco, Michael R Goga, Michele L Glendenning, Michele Perry Williams, Michelle J Glembin, Michelle M Noe Varga, Mohsen Rajabi Abhari, FDA, Monica E Murie, Mra Greenc, Nancy A Bellamy, Nantie, Nicholas C Mendiola, Nicholas P Diorio, Nicholas Z Lu, Nicola M Fenty Stewart, Nicole C Victoria, PhD, Nicole J Clausen, Nicole S Williams, Norman K Starks, Pablo Alcantara, Pal S Mayasandra, Paola S Barnett, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paul M Kawamoto, Paul W Moy, Paula M Laplant, Penny H Mccarver, Peter E Baker, Peterson, Phal K Chhun, Phung Thien Nguyen, Pradip N Akolkar, Rafael E Arroyo, Rafael Padilla, Ralph A Erickson, Randy D Baxter, Raymond T Oji, Rebecca Rodriguez, Regina T Brown, Richard S Andros, Richard W Berning, Robert C Steyert, Robert D Tollefsen, Robert J Ham, Roberta W Cunningham, Roger J Adams, Rosa J Motta, Ross J Grigsby, Russell K Riley, Samantha J Pinizzotto, D V M, Samina S Khan, Sandra A Hughes, Sandra L Shire, DMD, MPA, Sandra S Saniga, Seongeun Cho (Julia), PhD, Shafiq S Ahadi, Shalonda C Clifford, Sherbet L Samuels, Sherea L Dillon, Sherri J Jackson, Sonya L Karsik, RAC, Sripal R Mada, PhD, Stacey S Degarmo, Stuart W Russell, Sullan, Susan E Molchan, MD, Susan P Bruederle, Susanne M Richardson, MS RAC, Tara A Marshall, Tara C Alcazar, Tara K Carmody, Tawny L Colling, Tenzin Jangchup, That Q Dang, Thea C Grome, Thomas J Arista, Thomas W Nojek, Tiara Nbrown Crosen, Tong Zhou, Uruaku A Obasi, Veronica Fuentes, MS, Vioela J Caze, Walden H Lee, Wayne W Grundstrom, Xikui Chen (nmi), PhD, Yangmin Ning, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvonne E Lozano

Susan D Yuscius's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Lincare Inc. - Form 483, 2001-03-28
April, 2001 EIR Paul, Allan, Dr. - EIR, 2001-04-06
May, 2014 FDA 483 Professor Noel Gerard McElvaney - Form 483, 2014-05-02
September, 2003 FDA 483 Meda Pharmaceuticals Inc. - Form 483, 2003-09-19
April, 2018 FDA 483 Response Uptown Research Institute - Form 483R, 2018-04-19
September, 2006 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2006-09-29
August, 2010 EIR Hamilton Health Science Population Health Research Institute - EIR, 2010-08-20
July, 2009 EIR Charles River Laboratories Montreal ULC - EIR, 2009-07-31
January, 2010 FDA 483 Response Rowland, Kendrith, MD - Form 483R, 2010-02-03
January, 2010 EIR Rowland, Kendrith, MD - EIR, 2010-01-20
February, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-02-08
October, 2019 FDA 483 Frederick J. Snoy, M.D. - Form 483, 2019-10-11
May, 2011 FDA 483 MERICON INDUSTRIES, INC. - Form 483, 2011-05-27
December, 2000 FDA 483 Reddy, Duttula M.D. - Form 483, 2000-12-19
November, 2003 EIR AmericanAnalytical Chemistry Laboratories Corp. - EIR, 2003-11-24
October, 2002 FDA 483 Response AmericanAnalytical Chemistry Laboratories Corp. - Form 483R, 2002-11-20
November, 2010 FDA 483 Decatur Memorial Hospital Irb - Form 483, 2010-11-17
March, 2001 EIR Graham, Donald R., M.D. - EIR, 2001-03-07
December, 2008 EIR Barry Clemson, M.D. - EIR, 2008-12-18
August, 2007 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2007-08-17
June, 2000 FDA 483 Response Dr. E. Leen - Form 483R, 2000-10-25
September, 2003 EIR Meda Pharmaceuticals Inc. - EIR, 2003-09-19
June, 2000 FDA 483 Response Professor Thomas Vogl, M.D. - Form 483R, 2000-10-24
December, 2001 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2001-12-17
December, 2000 EIR Reddy, Duttula M.D. - EIR, 2000-12-19
October, 2002 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2002-10-25
May, 2000 FDA 483 Health Advance Institute - Form 483, 2000-05-03
February, 2001 EIR Nayak, Anjuli Seth, M.D. - EIR, 2001-02-23
June, 2000 EIR Dr. E. Leen - EIR, 2000-06-16
February, 2009 EIR Abbott Molecular, Inc. - EIR, 2009-02-13
May, 2000 EIR Health Advance Institute - EIR, 2000-05-03
September, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-09-15
September, 2000 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2000-09-15
April, 2018 FDA 483 Uptown Research Institute - Form 483, 2018-04-13
August, 2018 EIR Amita Health IRB - EIR, 2018-08-23
June, 2000 EIR Professor Thomas Vogl, M.D. - EIR, 2000-06-22
February, 2011 EIR Barry Clemson, M.D. - EIR, 2011-02-04
November, 2010 EIR Decatur Memorial Hospital Irb - EIR, 2010-11-17
September, 2013 FDA 483 Alasdair Coles, Ph.D FRCP - Form 483, 2013-09-13
November, 2009 FDA 483 Response Berger, Daniel M.D. - Form 483R, 2010-01-11
September, 2005 EIR Rising Pharma Holdings, Inc. - EIR, 2005-09-08
November, 2003 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2003-11-24
December, 2007 FDA 483 Aerosols Danville, Inc. dba Voyant Beauty - Form 483, 2007-12-07
November, 2009 EIR Berger, Daniel M.D. - EIR, 2009-11-24
December, 2008 FDA 483 Barry Clemson, M.D. - Form 483, 2008-12-18
November, 2009 FDA 483 Berger, Daniel M.D. - Form 483, 2009-11-24
August, 2016 EIR Experimur, A Frontage Company - EIR, 2016-08-26
November, 2003 FDA 483 Response AmericanAnalytical Chemistry Laboratories Corp. - Form 483R, 2003-11-24
November, 2018 EIR AbbVie Inc. - EIR, 2019-01-25
January, 2010 FDA 483 Rowland, Kendrith, MD - Form 483, 2010-01-20
April, 2018 EIR Uptown Research Institute - EIR, 2018-04-13
January, 2008 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2008-01-18
August, 2012 EIR Wolfgang Loidl - EIR, 2012-08-09
October, 2002 EIR AmericanAnalytical Chemistry Laboratories Corp. - EIR, 2002-10-25
December, 2008 FDA 483 Response Barry Clemson, M.D. - Form 483R, 2009-05-21
July, 2008 EIR Takeda Global Research & Development - EIR, 2008-07-14
May, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-05-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more